name: | Modafinil |
ATC code: | N06BA07 | route: | oral |
n-compartments | 1 |
Modafinil is a wakefulness-promoting agent approved for the treatment of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It has also been used off-label for various cognitive enhancement purposes.
Pharmacokinetic parameters reported for healthy adult volunteers, both male and female, after single oral administration.
Seng, KY, et al., & Lee, LS (2011). Population pharmacokinetics of modafinil and its acid and sulfone metabolites in Chinese males. Therapeutic drug monitoring 33(6) 719–729. DOI:10.1097/FTD.0b013e318237a9e9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22105589
Tao, G, et al., & Chenhui, D (2010). Population pharmacokinetics of modafinil in Chinese Han, Mongolian, Korean, Uygur, and Hui healthy subjects determined by nonlinear mixed-effects modeling. Therapeutic drug monitoring 32(2) 189–193. DOI:10.1097/FTD.0b013e3181cf27d3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20216121
Wu, KH, et al., & Lu, W (2012). Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China. Acta pharmacologica Sinica 33(11) 1401–1408. DOI:10.1038/aps.2012.124 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23103618